Paying users zone. Data is covered by .

  • Get to Bristol-Myers Squibb Co. for $15.99, or

  • get to whole website for at least 3 months from $49.99.


Statement of Cash Flows Quarterly Data

Difficulty: Beginner

The cash flow statement provides information about a company's cash receipts and cash payments during an accounting period, showing how these cash flaws link the ending cash balance to the beginning balance shown on the company's statement of financial position.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Bristol-Myers Squibb Co., Consolidated Statement of Cash Flows (quarterly data)

USD $ in millions

3 months ended Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013 Sep 30, 2013 Jun 30, 2013 Mar 31, 2013
Net earnings (loss)
Net (earnings) loss attributable to noncontrolling interest
Depreciation and amortization, net
Deferred income taxes
Stock-based compensation
Impairment charges
Pension settlements and amortization
Divestiture gains and royalties
Asset acquisition charges
Other adjustments
Accounts payable
Deferred income
Income taxes payable
Changes in operating assets and liabilities
Adjustments to reconcile net earnings (loss) to net cash provided by (used in) operating activities
Net cash provided by (used in) operating activities
Sale and maturities of marketable securities
Purchase of marketable securities
Capital expenditures
Divestiture and other proceeds
Acquisition and other payments
Net cash (used in) provided by investing activities
Short-term debt obligations, net
Issuance of long-term debt
Repayment of long-term debt
Repurchase of common stock
Net cash used in financing activities
Effect of exchange rates on cash and cash equivalents
Increase (decrease) in cash and cash equivalents
Source: Bristol-Myers Squibb Co., Quarterly and Annual Reports
Item Description The company
Net cash provided by (used in) operating activities The net cash from (used in) all of the entity's operating activities, including those of discontinued operations, of the reporting entity. Operating activities generally involve producing and delivering goods and providing services. Operating activity cash flows include transactions, adjustments, and changes in value that are not defined as investing or financing activities. Bristol-Myers Squibb Co.'s net cash provided by (used in) operating activities declined from Q3 2017 to Q4 2017 but then slightly increased from Q4 2017 to Q1 2018.